Delgado-Goñi T, Ortega-Martorell S, Ciezka M, Olier I, Candiota AP, Julià-Sapé M, Fernández F, Pumarola M, Lisboa PJ, Arús C. MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis. NMR Biomed. 2016 Jun;29(6):732-43. doi: 10.1002/nbm.3521. Epub 2016 Apr 8. PMID: 27061401.
Ciezka M, Acosta M, Herranz C, Canals JM, Pumarola M, Candiota AP, Arús C. Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation. J Neurooncol. 2016 Aug;129(1):67-76. doi: 10.1007/s11060-016-2164-3. Epub 2016 Jun 21. PMID: 27324642.,
Ferrer-Font L, Alcaraz E, Plana M, Candiota AP, Itarte E, Arús C. Protein Kinase CK2 Content in GL261 Mouse Glioblastoma. Pathol Oncol Res. 2016 Jul;22(3):633-7. doi: 10.1007/s12253-015-9987-7. Epub 2015 Oct 14. PMID: 26466942.
Castells Domingo X, Ferrer-Font L, Davila M, Candiota AP, Simões RV, Fernández-Coello A, Gabarrós A, Boluda S, Barceló A, Ariño J, Arús C. Improving Ribosomal RNA Integrity in Surgically Resected Human Brain Tumor Biopsies. Biopreserv Biobank. 2016 Apr;14(2):156-64. doi: 10.1089/bio.2015.0086. Epub 2016 Feb 17. PMID: 26886080.
